Many Americans living with diabetes now have access to insulin for just $35 a month, thanks to price cuts that took effect on January 1.
The country's three biggest insulin producers — Sanofi, Novo Nordisk and Eli Lilly — announced plans last year to cut monthly insulin prices, with some plans becoming effective this month.
